First Wave BioPharma Inc Live Stock Price Today, Share Analysis and Chart

Name: First Wave BioPharma Inc: Is Infosys Ltd. worth buying?
Item: First Wave BioPharma Inc
Rating: 0.56350
Author: Trendlyne DVM scores

about

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglu...

0.47 0.00 (0.00%)

31.88% Fall from 52W High

118.5K

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

22.5 / 100

No estimates available

First Wave BioPharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

First Wave BioPharma Inc Live Stock Price Today, Share Analysis and Chart

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglu...

31.88% Fall from 52W High

SWOT Analysis

First Wave BioPharma Inc Live Price Chart